The Wockhardt Group, previously a prominent player in the pharmaceutical industry, is facing severe difficulties. With mounting debts and a struggling business, the group's valuable assets are now scheduled for auction. This dramatic turn of events has sent shockwaves through the industry, spurring speculation within financial circles. It remains … Read More